Skip to main content
Erschienen in: Obesity Surgery 5/2017

Open Access 27.10.2016 | Original Contributions

Life with a Gastric Band. Long-Term Outcomes of Laparoscopic Adjustable Gastric Banding—a Retrospective Study

verfasst von: Piotr K. Kowalewski, Robert Olszewski, Andrzej Kwiatkowski, Natalia Gałązka-Świderek, Krzysztof Cichoń, Krzysztof Paśnik

Erschienen in: Obesity Surgery | Ausgabe 5/2017

Abstract

Background

Laparoscopic adjustable gastric banding (LAGB) is the third most popular bariatric procedure worldwide. Various authors present ambivalent long-term follow up results.

Methods

We revised records of the patients who underwent LAGB between 2003 and 2006 along with history of additional check-ins. Patients with outdated details were tracked with the national health insurance database and social media (Facebook). An online survey was sent. The patients who did not have their band removed were included in this study. We calculated the percent total weight loss (%TWL) and percent excess weight loss (%EWL), along with changes in body mass index (ΔBMI). Satisfactory weight loss was set at >50% EWL (for BMI = 25 kg/m2). Since eight patients gained weight, we decided to include negative values of %TWL, %EWL, and ΔBMI.

Results

One hundred seven patients underwent LAGB from 2003 to 2006. The mean follow-up time was 11.2 (±1.2) years. Eleven percent of patients were lost to follow up (n = 12). There was one perioperative death. Fifty-four of the patients (n = 57) had their band removed. Thirty-seven patients still have the band (39%) and were included in the study. The mean %EWL was 27% (−56–112%) and %TWL was 11% (−19–53%). Twelve patients achieved %EWL > 50% (32%). Thiry-two patients still suffer from obesity, with BMI over 30 kg/m2. Eight patients (22%) gained additional weight. Patients with %EWL > 50% suffered less from gastroesophageal reflux disease symptoms than those with EWL < 50% (p < 0.05).

Conclusions

Out of 107 cases, only 11.2% of patients with gastric band (n = 12) achieved satisfactory %EWL. Twenty–two percent of patients regained their weight or even exceeded it. Overall results suggest that LAGB is not an effective bariatric procedure in long term observation.

Introduction

Adjustable gastric banding was first introduced as a bariatric procedure in the mid-80s [1]. Its overall simplicity, and the development of laparoscopy allowed surgeons to implement a minimally invasive technique, which, by this day is known as laparoscopic adjustable gastric banding (LAGB) [2]. It is the third most popular bariatric surgery, representing 10% of all the procedures in 2013 [3]. Interestingly, in 2008 LAGB was the most commonly performed procedure for patients suffering from obesity, with 42.3% of all bariatric surgeries [4]. Bearing in mind this decrease, still over 40,000 patients undergo this operation worldwide every year, according to the 2013 survey. The overall change in popularity may be attributed to doubts regarding its effectiveness in the long-term research [5]. Yet, a number of large, prospective studies acknowledge LAGB as a successful bariatric procedure [6]. In our study, we would like to focus on the long-term history of patients who underwent LAGB and still live with a gastric band.

Aim

To evaluate long-term clinical outcomes of laparoscopic adjustable gastric banding (LAGB) regarding weight loss, physical activity and complaints of gastroesophageal reflux disease (GERD) in patients are living with the gastric band.

Materials and Methods

Our institution database was revised for the record of patients who underwent LAGB between 2003 and 2006. We have gathered the data on their weight, body mass index (BMI), and co-morbidities. The history of additional check-ins was revised. The patients who did not fulfill their check-ins and whose personal data was outdated were tracked using the national health insurance database, or found using social media (Facebook and LinkedIn) and its support groups. These patients received and filled out an online questionnaire regarding their current weight, medical history, complaints of GERD, physical activity habits—expressed by regular, over 30-min exercise routine, and sedentary behavior, assessed by hours spent siting down on a daily basis. The patients who did not have their band removed were included in this study. To measure the effectiveness of the procedure, the percentage total weight loss (%TWL), percentage excess weight loss (%EWL), and change in body mass index (ΔBMI) were calculated.
We calculated the excess weight (EW) from the weight before surgery subtracted by ideal body weight (IBW) for BMI of 25 kg/m2. Satisfactory weight loss after the surgery was defined by the EWL greater than 50%.
We performed the statistical analysis using “Statistica” software (StatSoft). Normality of the data was tested with Shapiro-Wilk test. Continuous variables were compared with the student t test. Categorical variables were compared using the chi2 test. Statistical significance was set at p < 0.05.
Since eight patients gained weight, we decided to include negative values of %TWL, %EWL, and ΔBMI.

Results

One hundred seven patients underwent LAGB between 2003 and 2006 in our institution. There was one perioperative death (0.09%). Eleven percent of patients were lost to follow up ( n = 12). Fifty-four percent of patients (n = 57) had their band removed. Out of the remaining group, 39% of patients (n = 37) still live with a functioning gastric band and were included in this study. The mean follow-up time was 11.2 (±1.2) years. There were 78% female (n = 29) and 22% male (n = 8) patients. The mean patients’ age was 37 years (ranging from 20 to 63) and mean BMI before the surgery was 42.3 (±4.3) (Table 1). Several complications led to the band removal. The main causes were the following: weight gain (40%), pouch slippage (25%), port complications, such as infection and dislocation (21%), pouch dilatation (16%), and band erosion (5%) (Table 2). The long-term outcomes of LAGB in the study group are presented in Table 3 and Fig. 1. The mean excess weight loss was 27% (−56–112%) and total weight loss was 11% (−19%–53%). Thirty-two percent of patients achieved %EWL > 50% (n = 12). 86% of patients (n = 32) still suffer from obesity, with BMI over 30 kg/m2. It should be noted that eight patients gained additional weight (22%), exceeding their body mass from before the surgery. Interestingly, mean maximum %EWL recorded in the follow-up reached 69%. Over half (57%) of the patients achieved it in the first year after the surgery.
Table 1
Demographic data
 
Value
Percent (SD) [range]
Gender (female/male)
29/8
78%/22%
Age
37
[20–63]
Mean weight (kg)
120.7
(±17.0) [90–150]
Mean BMI (kg/m2 )
42.3
(±4.3) [33.7–52.1]
Mean excess weight (kg)
49.3
(±12.7) [24.4–76.0]
Table 2
Causes of revisional surgery after LAGB
Causes
Number
Percent
Weight gain
23
40
Slippage
14
25
Pouch dilatation and reflux
9
16
Band erosion
3
5
Port problem (infection, dislocation)
12
21
Table 3
Long term outcomes of LAGB
 
Value
Percent (SD) [range]
Time of follow-up (years)
11.2
(±1.1)
%EWL
27%
(±38%) [−56–112%]
%TWL
11%
(±15%) [−19–53%]
ΔBMI
4.71
(±6.65) [−7.3–25.3]
Number of patients with %EWL > 50%
12
33%
Number of patients with weight gain
8
22%
Regarding physical activity and habits, 15 patients (41%) exercised regularly for at least 30 min daily. Mean sedentary time in all patients was 7 h per day. Therefore, the patients were divided into two groups according to the achieved %EWL over and under 50%, physical activity, and gained weight. These groups were then compared regarding different parameters. There was a statistically significant difference in GERD symptoms reported between patients with %EWL > 50% (group 1) and %EWL < 50% (group 2). Only 5 (42%) patients from group 1 suffered from GERD, compared to 19 (79%) from group 2 (p < 0.05). Other differences were not statistically significant (Table 4).
Table 4
Difference between patients with %EWL > 50% and %EWL < 50%
 
Group 1 (EWL > 50%) n = 12
Group 2 (EWL < 50%) n = 25
p value
GERD symptoms
5 (42%)
20 (80%)
<0.05a
Sedentary hours (mean)
5.8 (±3)
7.6 (±2.6)
p = 0.069b
Physically active
6 (50%)
9 (36%)
p = 0.41a
aChi2 test
b t student test

Discussion

According to WHO, obesity affected 600 million people worldwide in 2014. Thirteen percent of the world population was suffering from obesity. These numbers doubled since 1980. Over the years, new methods of treatment became available to patients. Current research supports bariatric surgery as the most effective one. [7, 8]. Out of all the variety of existing procedures, LAGB is the third most popular in the world, according to the survey from 2013. Ten percent of the bariatric patients, almost 40,000 people worldwide, undergo this procedure every year [3]. In Poland, LAGB is preceded by laparoscopic sleeve gastrectomy (LSG), laparoscopic Roux-en-Y gastric bypass (LRYGB), and mini gastric bypass (MGB). Adjustable band accounts for 7.6% of bariatric procedures [9]. There are several qualities that make LAGB such a popular procedure. It is fairly uncomplicated in the hands of an experienced surgeon. It has good short-term effects, and is mostly reversible. Even in our study, 69 % of the patients achieved satisfying %EWL over 50% at some point after the surgery. Yet when it comes to long-term results, the outcomes are not as favorable. Although O’Brien et al. report a stunning 47% excess weight loss in a 15-year follow-up, yet over 50% of patients had their band removed, with or without additional bariatric surgery, such as LRYGB or LSG [6]. Other authors do not present such favorable long-term outcomes of LAGB. Aarts et al. report that only 22% of all LAGB patients maintain a functioning band with good results. Fifty-three percent of the patients underwent a revisional procedure and/or band removal [10]. Sutter et al. underlines linear progression of major complications and even states in the conclusion that LAGB should not be considered a procedure of choice for treating obesity [5]. Himpens et al. also reaches the conclusion that LAGB long term effects are poor due to a high reoperation rate [11]. When it comes to co-morbidities, its reduction in short-term follow-up is not maintained in the long term [10]. Out of many studied co-morbidities, only glucose tolerance improves and maintains its improvement in long term observation [12]. GERD and its symptoms are also frequently mentioned regarding bariatric surgery. Naik et al. state that adjustable gastric banding worsens GERD or even forms de novo cases in previously asymptomatic patients [13]. Greater amount of GERD and dysphagia symptoms in patients with %EWL lower than 50% in our study may suggest dietary inaccuracy in this particular group. Overall, bariatric surgery tends to improve patients’ physical activity [14]. Yet, in our observation, only 41% of patients remain physically active, with average daily sedentary time as long as 7 h.

Conclusions

Only 39% of patients still maintain a functioning band after over 10 years. The rest of the patients had their band removed due to various complications. Out of all of the patients, only 11.2% of them achieved satisfactory %EWL over 50%, which means that the band fail rate reached 88.8%. Twenty-two percent of patients from the study group regained their weight or even exceeded it. Over half of the patients suffer from dysphagia, more often when weight loss is not satisfactory, which suggests that these patients do not comply to dietary guidelines. Overall results suggest that LAGB is not an effective bariatric procedure in long term observation.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Kuzmak L. Silicone gastric banding: a simple and effective operation for morbid obesity. Contemp. Surg. 1986; 28. Kuzmak L. Silicone gastric banding: a simple and effective operation for morbid obesity. Contemp. Surg. 1986; 28.
2.
Zurück zum Zitat Cadière GB, Bruyns J, Himpens J, et al. Laparoscopic gastroplasty for morbid obesity. Br J Surg. 1994;81:1524.CrossRefPubMed Cadière GB, Bruyns J, Himpens J, et al. Laparoscopic gastroplasty for morbid obesity. Br J Surg. 1994;81:1524.CrossRefPubMed
3.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefPubMed Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefPubMed
4.
Zurück zum Zitat Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg Springer Science + Business Media. 2009;19:1605–11. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg Springer Science + Business Media. 2009;19:1605–11.
5.
Zurück zum Zitat Suter M, Calmes JM, Paroz A, et al. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg. 2006;16:829–35.CrossRefPubMed Suter M, Calmes JM, Paroz A, et al. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg. 2006;16:829–35.CrossRefPubMed
6.
Zurück zum Zitat O’Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257:87–94.CrossRefPubMed O’Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257:87–94.CrossRefPubMed
7.
Zurück zum Zitat Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.CrossRefPubMedPubMedCentral Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641. Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.
9.
Zurück zum Zitat Janik MR, Stanowski E, Paśnik K. Present status of bariatric surgery in Poland. Videosurgery Miniinv. 2016;1:22–5.CrossRef Janik MR, Stanowski E, Paśnik K. Present status of bariatric surgery in Poland. Videosurgery Miniinv. 2016;1:22–5.CrossRef
10.
Zurück zum Zitat Aarts EO, Dogan K, Koehestanie P, et al. Long-term results after laparoscopic adjustable gastric banding: a mean fourteen year follow-up study. Surg Obes Relat Dis. 2014;10:633–40.CrossRefPubMed Aarts EO, Dogan K, Koehestanie P, et al. Long-term results after laparoscopic adjustable gastric banding: a mean fourteen year follow-up study. Surg Obes Relat Dis. 2014;10:633–40.CrossRefPubMed
11.
Zurück zum Zitat Himpens J, Cadière G-B, Bazi M, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg American Medical Association. 2011;146:802–7.CrossRef Himpens J, Cadière G-B, Bazi M, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg American Medical Association. 2011;146:802–7.CrossRef
12.
Zurück zum Zitat Zakaria AS, Rossetti L, Cristina M, et al. Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis. 12:587–95. Zakaria AS, Rossetti L, Cristina M, et al. Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis. 12:587–95.
13.
Zurück zum Zitat Naik RD, Choksi YA, Vaezi MF. Impact of weight loss surgery on esophageal physiology. Gastroenterol Hepatol (N Y). 2015;11:801–9. Naik RD, Choksi YA, Vaezi MF. Impact of weight loss surgery on esophageal physiology. Gastroenterol Hepatol (N Y). 2015;11:801–9.
14.
Zurück zum Zitat King WC, Chen J-Y, Belle SH, et al. Change in pain and physical function following bariatric surgery for severe obesity. JAMA. 2016;315:1362–71.CrossRefPubMedPubMedCentral King WC, Chen J-Y, Belle SH, et al. Change in pain and physical function following bariatric surgery for severe obesity. JAMA. 2016;315:1362–71.CrossRefPubMedPubMedCentral
Metadaten
Titel
Life with a Gastric Band. Long-Term Outcomes of Laparoscopic Adjustable Gastric Banding—a Retrospective Study
verfasst von
Piotr K. Kowalewski
Robert Olszewski
Andrzej Kwiatkowski
Natalia Gałązka-Świderek
Krzysztof Cichoń
Krzysztof Paśnik
Publikationsdatum
27.10.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 5/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2435-2

Weitere Artikel der Ausgabe 5/2017

Obesity Surgery 5/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.